The Impact of Body Mass Index in the Endometrial Microbiome in IVF Treatments
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Infertility Female
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 20 years and 42 years
- Gender
- Only males
Description
This study is going to clarify endometrial, vaginal and anal microbiome variety between obese and normal weight patients. In the first group, the body mass index (BMI) of patients will be higher than 30 and in the other group, patients will be in their normal weight BMI 20-25. The samples are going ...
This study is going to clarify endometrial, vaginal and anal microbiome variety between obese and normal weight patients. In the first group, the body mass index (BMI) of patients will be higher than 30 and in the other group, patients will be in their normal weight BMI 20-25. The samples are going to be examined in the time of the embryo transfer and microbiome will be analyzed in laboratory specialized in NGS techniques.
Tracking Information
- NCT #
- NCT04168567
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Katja Ahinko Tampere University Hospital
Get Well Soon